These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 11802199

  • 1. Molecular staging of colorectal cancer in African-American and Caucasian patients using phenotypic expression of p53, Bcl-2, MUC-1 AND p27(kip-1).
    Grizzle WE, Manne U, Weiss HL, Jhala N, Talley L.
    Int J Cancer; 2002 Feb 01; 97(4):403-9. PubMed ID: 11802199
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Analysis of the correlation between p53 and bcl-2 expression with staging and prognosis of the colorectal adenocarcinoma.
    Lustosa SA, Logullo A, Artigiani R, Saad SS, Goldenberg A, Matos D.
    Acta Cir Bras; 2005 Feb 01; 20(5):353-7. PubMed ID: 16186958
    [Abstract] [Full Text] [Related]

  • 5. Cyclin E, p27 and mutant p53 do not predict the prognosis in AJCC stage II colorectal carcinomas.
    Lim YJ, Kim YH, Ahn GH, Chun HK, Jang WY, Lee JH, Son HJ, Rhee PL, Kim JJ, Paik SW, Yoo BC, Rhee JC.
    Korean J Gastroenterol; 2004 Dec 01; 44(6):314-20. PubMed ID: 15665575
    [Abstract] [Full Text] [Related]

  • 6. Nuclear accumulation of p53 in colorectal adenocarcinoma: prognostic importance differs with race and location of the tumor.
    Manne U, Weiss HL, Myers RB, Danner OK, Moron C, Srivastava S, Grizzle WE.
    Cancer; 1998 Dec 15; 83(12):2456-67. PubMed ID: 9874449
    [Abstract] [Full Text] [Related]

  • 7. Prognostic factors in resectable pancreatic cancer: p53 and bcl-2.
    Bold RJ, Hess KR, Pearson AS, Grau AM, Sinicrope FA, Jennings M, McConkey DJ, Bucana CD, Cleary KR, Hallin PA, Chiao PJ, Abbruzzese JL, Evans DB.
    J Gastrointest Surg; 1999 Dec 15; 3(3):263-77. PubMed ID: 10481119
    [Abstract] [Full Text] [Related]

  • 8. Relationship among p53, stage, and prognosis of large bowel cancer.
    Nathanson SD, Linden MD, Tender P, Zarbo RJ, Jacobsen G, Nelson LT.
    Dis Colon Rectum; 1994 Jun 15; 37(6):527-34. PubMed ID: 8200229
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Expression profiling of colorectal carcinomas using tissue microarrays: cell cycle regulatory proteins p21, p27, and p53 as immunohistochemical prognostic markers in univariate and multivariate analysis.
    Prall F, Ostwald C, Nizze H, Barten M.
    Appl Immunohistochem Mol Morphol; 2004 Jun 15; 12(2):111-21. PubMed ID: 15354735
    [Abstract] [Full Text] [Related]

  • 11. Combined role of tumor angiogenesis, bcl-2, and p53 expression in the prognosis of patients with colorectal carcinoma.
    Giatromanolaki A, Stathopoulos GP, Tsiompanou E, Papadimitriou C, Georgoulias V, Gatter KC, Harris AL, Koukourakis MI.
    Cancer; 1999 Oct 15; 86(8):1421-30. PubMed ID: 10526268
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Associations of beta-catenin alterations and MSI screening status with expression of key cell cycle regulating proteins and survival from colorectal cancer.
    Wangefjord S, Brändstedt J, Lindquist KE, Nodin B, Jirström K, Eberhard J.
    Diagn Pathol; 2013 Jan 21; 8():10. PubMed ID: 23337059
    [Abstract] [Full Text] [Related]

  • 14. Comparative analysis of prognostic significance of molecular markers of apoptosis with clinical stage and tumor differentiation in patients with colorectal cancer: a single institute experience.
    Ivanov K, Kolev N, Tonev A, Nikolova G, Krasnaliev I, Softova E, Tonchev A.
    Hepatogastroenterology; 2009 Jan 21; 56(89):94-8. PubMed ID: 19453036
    [Abstract] [Full Text] [Related]

  • 15. Paradoxical correlations of cyclin-dependent kinase inhibitors p21waf1/cip1 and p27kip1 in metastatic colorectal carcinoma.
    Cheng JD, Werness BA, Babb JS, Meropol NJ.
    Clin Cancer Res; 1999 May 21; 5(5):1057-62. PubMed ID: 10353738
    [Abstract] [Full Text] [Related]

  • 16. Thymidylate synthase expression, p53, bcl-2, Ki-67 and p27 in colorectal cancer: relationships with tumor recurrence and survival.
    Rosati G, Chiacchio R, Reggiardo G, De Sanctis D, Manzione L.
    Tumour Biol; 2004 May 21; 25(5-6):258-63. PubMed ID: 15627889
    [Abstract] [Full Text] [Related]

  • 17. Prognostic significance of p27(kip1) protein expression and spontaneous apoptosis in patients with colorectal adenocarcinomas.
    Tenjo T, Toyoda M, Okuda J, Watanabe I, Yamamoto T, Tanaka K, Ohtani M, Nohara T, Kawasaki H, Tanigawa N.
    Oncology; 2000 May 21; 58(1):45-51. PubMed ID: 10644940
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Scoring of p53, VEGF, Bcl-2 and APAF-1 immunohistochemistry and interobserver reliability in colorectal cancer.
    Zlobec I, Steele R, Michel RP, Compton CC, Lugli A, Jass JR.
    Mod Pathol; 2006 Sep 21; 19(9):1236-42. PubMed ID: 16741523
    [Abstract] [Full Text] [Related]

  • 20. Prognostic markers for colorectal cancer: expression of P53 and BCL2.
    Pereira H, Silva S, Julião R, Garcia P, Perpétua F.
    World J Surg; 1997 Feb 21; 21(2):210-3. PubMed ID: 8995081
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.